Citigroup Maintains Neutral on QuidelOrtho, Lowers Price Target to $13

Benzinga Newsdesk www.benzinga.com Negative 80.6%

Neg 80.6% Neu 0% Pos 0%

Citigroup analyst Patrick Donnelly maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and lowers the price target from $30 to $13.